Predicting Survival in Liver Cancer Using Vasculogenic Mimicry Genes
Author Information
Author(s): Wang Jingyun, Gao Rong, Qi Jian, Xing Yingru, Hong Bo, Wang Hongzhi, Nie Jinfu
Primary Institution: School of Medicine, Anhui University of Science and Technology
Hypothesis
The study investigates the predictive value of vasculogenic mimicry (VM) related genes for the survival and prognosis of hepatocellular carcinoma (HCC) patients and their role in the tumor microenvironment.
Conclusion
VM Score may serve as a promising prognostic biomarker for HCC and provide new ideas for immunotherapy in HCC patients.
Supporting Evidence
- VM Score was constructed and validated using three genes: SPP1, ADAMTS5, and ZBP1.
- Patients with low VM Scores showed significant survival benefits compared to those with high VM Scores.
- The study found that VM Score was an independent prognostic factor for HCC.
Takeaway
Researchers looked at certain genes to see if they could help predict how long liver cancer patients might live and how their tumors behave.
Methodology
The study used unsupervised clustering, LASSO regression, and Cox regression to analyze gene expression and clinical data from HCC patients.
Potential Biases
The reliance on retrospective data may introduce bias.
Limitations
The study relied on public databases for data, which may lack detailed clinical information and the sample size may not fully represent the entire HCC patient population.
Participant Demographics
The study included HCC patients from various datasets, but specific demographic details were not provided.
Statistical Information
P-Value
p<0.05
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website